Diversified, LLC Novo Nordisk A S Transaction History

Diversified, LLC

$861 Million
Q3 2024

A detailed history of Diversified, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Diversified, LLC holds 6,216 shares of NVO stock, worth $653,052. This represents 0.09% of its overall portfolio holdings.

Number of Shares

6,216

Previous 6,123 1.52%

Holding current value

$653,052

Previous $873,000 15.23%

% of portfolio

0.09%

Previous 0.11%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$119.07 - $145.42 $11,073 - $13,524	93 Added 1.52%	6,216 $740,000
Q2 2024 Jul 24, 2024	BUY	$122.71 - $146.91 $62,459 - $74,777	509 Added 9.07%	6,123 $873,000
Q1 2024 May 02, 2024	BUY	$102.11 - $135.92 $63,001 - $83,862	617 Added 12.35%	5,614 $720,000
Q4 2023 Feb 01, 2024	SELL	$87.78 - $105.45 $3,686 - $4,428	-42 Reduced 0.83%	4,997 $516,000
Q3 2023 Nov 02, 2023	BUY	$90.94 - $199.54 $258,360 - $566,893	2,841 Added 129.25%	5,039 $458,000
Q2 2023 Jul 26, 2023	SELL	$155.98 - $172.65 $6,551 - $7,251	-42 Reduced 1.88%	2,198 $355,000
Q1 2023 Apr 24, 2023	BUY	$132.34 - $159.14 $1,455 - $1,750	11 Added 0.49%	2,240 $356,000
Q4 2022 Feb 13, 2023	BUY	$102.55 - $135.33 $228,583 - $301,650	2,229 New	2,229 $301,000
Q2 2022 Jul 19, 2022	BUY	$103.24 - $121.81 $516 - $609	5 Added 0.26%	1,959 $218,000
Q4 2021 Jan 31, 2022	BUY	$95.88 - $117.08 $187,349 - $228,774	1,954 New	1,954 $219,000
Q1 2021 May 05, 2021	SELL	$67.06 - $75.82 $129,761 - $146,711	-1,935 Closed	0 $0
Q4 2020 Jan 26, 2021	BUY	$63.89 - $73.8 $123,627 - $142,803	1,935 New	1,935 $134,000

Others Institutions Holding NVO

# of Institutions

1,954

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $237B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Diversified, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Diversified, LLC with notifications on news.

Account